Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Targeting PTEN can improve healing in venous leg ulcers.

Extracellular vesicles could offer precise treatments for psychiatric conditions by targeting brain networks.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Blocking GPR91 can help prevent and reverse hair loss in androgenetic alopecia.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Belatacept may be a promising treatment for alopecia areata.

Restoring nerve-macrophage communication may help treat autoimmune diseases.

Statins may help treat alopecia areata by reducing harmful immune interactions.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

EGFR-targeted cancer therapy can cause skin issues starting at hair follicles, leading to inflammation.

Immune activities and specific genes are important in male pattern baldness.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Modifying gut bacteria with pro- and postbiotics may help treat hair loss.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.